This website uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Statement for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time. I accept / More info
For more information on which cookies we use then please refer to our Cookie Policy.
Setting up the KWM International Center is a significant strategic deployment for the firm.
King & Wood Mallesons’ cross-border team, advised Luye Pharma Hong Kong Limited (“Luye Pharma”) on its transaction signed with AstraZeneca relating...
Analysis of the 2018-19 Australian Federal Budget: significant reforms for corporates, small business and personal tax.
King & Wood Mallesons (KWM) was the biggest winner with 12 awards at the Thomson Reuters ALB China Law Awards 2018 held in Beijing.
We explore how international arbitration has adapted and will continue to adapt in 2018 to global challenges and opportunities.
On August 1, 2018, the U.S. Senate passed the FIRRMA of 2018 as part of the 2019 National Defense Authorization Act.
Welcome Jun Kang to our impressive KWM U.S. team.
The Bureau of Industry and Security issued a rule amending EAR by adding forty-four Chinese entities to the Entity List.
This transaction is a typical Silicon Valley venture capital financing transaction.